From fixed antibody–drug conjugates to programmable therapeutics
Trends in Cancer · 2026-11 · 12 (11) · 997-999
DOI: 10.1016/j.trecan.2026.08.012 ↗Kurz gefasst
Kommentar in der Zeitschrift Trends in Cancer, 2026-11. Verfasst von Xinlei Zhuang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Precision Medicine and Biopharmaceuticals, School of Pharmacy, Zhejiang University, Hangzhou, China. Electronic address: zhuangxinlei@z…. Hauptthemen laut MEDLINE: Immunoconjugates, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 10 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Province Science and Technology Department, Zhejiang Province Natural Science Foundation.
Abstract (Originalsprache)
Antibody-drug conjugates have long been designed as fixed therapeutic entities. In Nature, Simó et al. introduce in vivo molecular assembly as an alternative strategy, prompting a broader question: could future cancer therapeutics be engineered by programming molecular interactions within patients rather than constructing increasingly complex drugs beforehand?
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Precision Medicine and Biopharmaceuticals, School of Pharmacy, Zhejiang University, Hangzhou, China. Electronic address: zhuangxinlei@zju.edu.cn.
- Laboratory of Precision Medicine and Biopharmaceuticals, School of Pharmacy, Zhejiang University, Hangzhou, China; Department of Pharmacy, the Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang…
Förderung
- National Natural Science Foundation of China
- Zhejiang Province Science and Technology Department
- Zhejiang Province Natural Science Foundation
Zitieren
APA
Zhuang, X., & Pan, L. (2026). From fixed antibody–drug conjugates to programmable therapeutics. Trends in Cancer, 12(11), 997-999. https://doi.org/10.1016/j.trecan.2026.08.012
Vancouver
Zhuang X, Pan L. From fixed antibody–drug conjugates to programmable therapeutics. Trends in Cancer. 2026;12(11):997-999. doi:10.1016/j.trecan.2026.08.012
BibTeX
@article{Zhuang2026,
author = {Zhuang, Xinlei and Pan, Liqiang},
title = {From fixed antibody–drug conjugates to programmable therapeutics},
journal = {Trends in Cancer},
year = {2026},
volume = {12},
number = {11},
pages = {997--999},
doi = {10.1016/j.trecan.2026.08.012}
}
EUVIMED